EUVIMEDEUVIMED entdecken
Crossref

Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies

Rufus W Burlingame

Clinical and Applied Immunology Reviews · 2004

DOI: 10.1016/j.cair.2004.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Immunology Reviews, 2004. Verfasst von Rufus W Burlingame. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Burlingame, R. W. (2004). Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clinical and Applied Immunology Reviews. https://doi.org/10.1016/j.cair.2004.04.002

Vancouver

Burlingame RW. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clinical and Applied Immunology Reviews. 2004. doi:10.1016/j.cair.2004.04.002

BibTeX
@article{Burlingame2004,
  author = {Burlingame, Rufus W},
  title = {Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies},
  journal = {Clinical and Applied Immunology Reviews},
  year = {2004},
  doi = {10.1016/j.cair.2004.04.002}
}
Kostenlos starten →